These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 19884611)

  • 1. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms.
    Kwon JS; Joo YH; Nam HJ; Lim M; Cho EY; Jung MH; Choi JS; Kim B; Kang DH; Oh S; Park T; Hong KS
    Arch Gen Psychiatry; 2009 Nov; 66(11):1233-41. PubMed ID: 19884611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between genetic variants of DLGAP3 and SLC1A1 affecting the risk of atypical antipsychotics-induced obsessive-compulsive symptoms.
    Ryu S; Oh S; Cho EY; Nam HJ; Yoo JH; Park T; Joo YH; Kwon JS; Hong KS
    Am J Med Genet B Neuropsychiatr Genet; 2011 Dec; 156B(8):949-59. PubMed ID: 21990008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder.
    Dickel DE; Veenstra-VanderWeele J; Cox NJ; Wu X; Fischer DJ; Van Etten-Lee M; Himle JA; Leventhal BL; Cook EH; Hanna GL
    Arch Gen Psychiatry; 2006 Jul; 63(7):778-85. PubMed ID: 16818867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the glutamate transporter gene SLC1A1 and obsessive-compulsive symptoms induced by second-generation antipsychotic agents.
    Schirmbeck F; Nieratschker V; Frank J; Englisch S; Rausch F; Meyer-Lindenberg A; Rietschel M; Zink M
    Psychiatr Genet; 2012 Oct; 22(5):245-52. PubMed ID: 22531293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms.
    Cai J; Zhang W; Yi Z; Lu W; Wu Z; Chen J; Yu S; Fang Y; Zhang C
    Psychopharmacology (Berl); 2013 Nov; 230(1):49-55. PubMed ID: 23660601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of the association of serotonin transporter gene polymorphism with obsessive-compulsive disorder.
    Lin PY
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):683-9. PubMed ID: 17291658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.
    Arnold PD; Sicard T; Burroughs E; Richter MA; Kennedy JL
    Arch Gen Psychiatry; 2006 Jul; 63(7):769-76. PubMed ID: 16818866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder.
    Stewart SE; Fagerness JA; Platko J; Smoller JW; Scharf JM; Illmann C; Jenike E; Chabane N; Leboyer M; Delorme R; Jenike MA; Pauls DL
    Am J Med Genet B Neuropsychiatr Genet; 2007 Dec; 144B(8):1027-33. PubMed ID: 17894418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.
    Alonso P; Gratacòs M; Menchón JM; Saiz-Ruiz J; Segalàs C; Baca-García E; Labad J; Fernández-Piqueras J; Real E; Vaquero C; Pérez M; Dolengevich H; González JR; Bayés M; de Cid R; Vallejo J; Estivill X
    Biol Psychiatry; 2008 Mar; 63(6):619-28. PubMed ID: 17884018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genetic family-based association study of OLIG2 in obsessive-compulsive disorder.
    Stewart SE; Platko J; Fagerness J; Birns J; Jenike E; Smoller JW; Perlis R; Leboyer M; Delorme R; Chabane N; Rauch SL; Jenike MA; Pauls DL
    Arch Gen Psychiatry; 2007 Feb; 64(2):209-14. PubMed ID: 17283288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Schizophrenic with obsessive-compulsive disorder or symptoms].
    Doubremelle C; Millet B; Olie JP
    Encephale; 2000; 26(2):81-8. PubMed ID: 10858921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and pharmacogenetic study of glutamate transporter (SLC1A1) in Iranian patients with obsessive-compulsive disorder.
    Abdolhosseinzadeh S; Sina M; Ahmadiani A; Asadi S; Shams J
    J Clin Pharm Ther; 2019 Feb; 44(1):39-48. PubMed ID: 30315580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-alpha polymorphisms are associated with obsessive-compulsive disorder.
    Hounie AG; Cappi C; Cordeiro Q; Sampaio AS; Moraes I; Rosário MC; Palácios SA; Goldberg AC; Vallada HP; Machado-Lima A; Nakano E; Kalil J; Pauls D; Pereira CA; Guilherme L; Miguel EC
    Neurosci Lett; 2008 Sep; 442(2):86-90. PubMed ID: 18639610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom structure of antipsychotic-induced obsessive compulsive symptoms in schizophrenia patients.
    Kim JH; Ryu S; Nam HJ; Lim M; Baek JH; Joo YH; Kwon JS; Ha TH; Hong KS
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):75-9. PubMed ID: 22617280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
    Stengler-Wenzke K
    Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder.
    Wendland JR; Moya PR; Timpano KR; Anavitarte AP; Kruse MR; Wheaton MG; Ren-Patterson RF; Murphy DL
    Arch Gen Psychiatry; 2009 Apr; 66(4):408-16. PubMed ID: 19349310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of patients with schizophrenia, obsessive-compulsive disorder, and schizophrenia with accompanying obsessive-compulsive symptoms].
    Güleç G; Güneş E; Yenilmez C
    Turk Psikiyatri Derg; 2008; 19(3):247-56. PubMed ID: 18791877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic susceptibility to obsessive-compulsive hoarding: the contribution of neurotrophic tyrosine kinase receptor type 3 gene.
    Alonso P; Gratacòs M; Menchón JM; Segalàs C; González JR; Labad J; Bayés M; Real E; de Cid R; Pertusa A; Escaramís G; Vallejo J; Estivill X
    Genes Brain Behav; 2008 Oct; 7(7):778-85. PubMed ID: 18616610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate transporter gene polymorphisms and obsessive-compulsive disorder: A case-control association study.
    de Salles Andrade JB; Giori IG; Melo-Felippe FB; Vieira-Fonseca T; Fontenelle LF; Kohlrausch FB
    J Clin Neurosci; 2019 Apr; 62():53-59. PubMed ID: 30661718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
    Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.